FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias

ChEBI2019-03-18 更新2026-07-12 收录

急性早幼粒细胞白血病治疗

FLT3-ITD药物反应

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-7566 数据链接链接失效反馈

官方服务：

资源简介：

FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias

创建时间：

2019-03-18

(-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia

纳米药物递送

急性早幼粒细胞白血病治疗

Realgar and (-)-Epigallocatechin-3-gallate (EGCG) are natural medicines that inhibit cancer cell growth, resulting in inhibition of formation and development of tumors. The anticancer effects of realg

NIAID Data Ecosystem70

Table_1_Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond.docx

急性早幼粒细胞白血病治疗

口服三氧化二砷临床应用

This account describes how orally administered Arsenic-trioxide (ATO) therapy influences the epidemiology of acute promyelocytic leukaemia (APL), and how the experience that ensued may expand the indi

NIAID Data Ecosystem20

Therapy-induced PML nuclear body re-formation and p53 activation trigger acute promyelocytic leukaemia cure

急性早幼粒细胞白血病治疗

P53信号通路

The therapy-induced PML/RARA catabolism elicits the loss of APL-initiating cell self-renewal through PML NB reformation and P53 activation. These results explain the curative activity of the RA/arseni

NIAID Data Ecosystem10

Therapy-induced PML nuclear body re-formation and p53 activation trigger acute promyelocytic leukaemia cure. Mus musculus

急性早幼粒细胞白血病治疗

肿瘤分子病理学

NIAID Data Ecosystem40

Effect of cytoreductive chemotherapy on differentiation syndrome in patients with newly diagnosed acute promyelocytic leukemia

急性早幼粒细胞白血病治疗

分化综合征评估

This data collected the clinical characteristics and treatment efficacy of 141 newly diagnosed APL patients.

Figshare2023-11-05 更新10